CytoDyn (CYDY)
OTHER OTC:CYDY
Holding CYDY?
Track your performance easily

CytoDyn (CYDY) Financial Statements

642 Followers

CytoDyn Financial Overview

CytoDyn's market cap is currently ―. The company's EPS TTM is $-0.024; its P/E ratio is -5.02; CytoDyn is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Aug 24May 24Feb 24Nov 23Aug 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ 20.39M$ -20.22M$ -10.36M$ -5.95M$ -10.37M
EBITDA$ 20.52M$ -20.09M$ -10.35M$ -5.80M$ -9.60M
Net Income Common Stockholders$ 19.23M$ -17.16M$ -12.29M$ -9.56M$ -11.94M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 24.92M$ 3.11M$ 1.40M$ 147.00K$ 2.03M
Total Assets$ 28.02M$ 11.14M$ 10.27M$ 9.24M$ 12.41M
Total Debt$ 29.02M$ 29.93M$ 30.34M$ 33.13M$ 33.35M
Net Debt$ 4.10M$ 26.82M$ 28.94M$ 32.98M$ 31.31M
Total Liabilities$ 113.23M$ 127.89M$ 129.65M$ 123.62M$ 129.30M
Stockholders Equity$ -85.21M$ -116.76M$ -119.38M$ -114.38M$ -116.89M
Cash Flow-
Free Cash Flow$ 5.44M$ -1.65M$ -2.33M$ -2.50M$ -4.50M
Operating Cash Flow$ 5.44M$ -1.65M$ -2.33M$ -2.50M$ -4.50M
Investing Cash Flow-----
Financing Cash Flow$ 9.67M$ 3.44M$ 3.63M$ 654.00K$ 4.02M
Currency in USD

CytoDyn Earnings and Revenue History

CytoDyn Debt to Assets

CytoDyn Cash Flow

CytoDyn Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis